Acetylcholine
- Generic Name
- Acetylcholine
- Brand Names
- Miochol
- Drug Type
- Small Molecule
- Chemical Formula
- C7H16NO2
- CAS Number
- 51-84-3
- Unique Ingredient Identifier
- N9YNS0M02X
- Background
A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, bu...
- Indication
Used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.
- Associated Conditions
- -
- Associated Therapies
- -
The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow
- Conditions
- Interventions
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- University Hospital, Linkoeping
- Target Recruit Count
- 90
- Registration Number
- NCT04777383
- Locations
- 🇸🇪
University Hospital Linköping, Linköping, Östergötland, Sweden
Targeting ER Stress in Vascular Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Colorado State University
- Target Recruit Count
- 17
- Registration Number
- NCT04001647
- Locations
- 🇺🇸
Colorado State University, Fort Collins, Colorado, United States
Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training
- Conditions
- Interventions
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Colorado State University
- Registration Number
- NCT03972683
- Locations
- 🇺🇸
Colorado State University, Fort Collins, Colorado, United States
HeartPhone Cancer Survivors Trial 2019
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- Penn State University
- Target Recruit Count
- 3
- Registration Number
- NCT03953326
- Locations
- 🇺🇸
The Pennsylvania State University, University Park, Pennsylvania, United States
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Colorado State University
- Target Recruit Count
- 9
- Registration Number
- NCT03738943
- Locations
- 🇺🇸
Human Performance and Clinical Research Laboratory, Fort Collins, Colorado, United States
Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 54
- Registration Number
- NCT03462017
- Locations
- 🇩🇪
Investigational Site Number 2760001, Neuss, Germany
🇩🇪Investigational Site Number 2760002, Mainz, Germany
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
- Conditions
- Interventions
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 6
- Registration Number
- NCT03446612
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.
- Conditions
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2024-02-07
- Target Recruit Count
- 29
- Registration Number
- NCT02987465
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Vascular Function and Uterine Fibroids
- First Posted Date
- 2014-04-25
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 28
- Registration Number
- NCT02123069
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Gladwin, Mark, MD
- Target Recruit Count
- 12
- Registration Number
- NCT01848301
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.